Locust Walk

YTD

ALL

Why Robinhood?

You can watch Locust Walk and buy or sell other stocks, ETFs, and their options commission-free!

About LWAC

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2).

CEO

Craig R. Jalbert

CEOCraig R. Jalbert

Employees

—

Employees—

Headquarters

Solana Beach, California

HeadquartersSolana Beach, California

Founded

2012

Founded2012

Employees

—

Employees—

LWAC Key Statistics

Market cap

66.92M

Market cap66.92M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

617.33

Average volume617.33

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.2848

52 Week high$0.2848

52 Week low

—

52 Week low—

People also own

Based on the portfolios of people who own LWAC. This list is generated using Robinhood data, and it’s not a recommendation.